J Cardiovasc Imaging.  2018 Jun;26(2):75-84. 10.4250/jcvi.2018.26.e2.

Correlation between Echocardiographic Pulmonary Artery Pressure Estimates and Right Heart Catheterization Measurement in Liver Transplant Candidates

• Habash F
• Gurram P
• Almomani A
• Duarte A
• Hakeem A
• Vallurupalli S
• Bhatti S

• KMID: 2415457
• DOI: http://doi.org/10.4250/jcvi.2018.26.e2

Abstract

BACKGROUND
Patients undergoing liver transplant have worse outcomes in the presence of pulmonary hypertension. Correlation between echocardiography and catheterization derived pressures in this population is not well studied. Our study's aim is to show the relationship between pulmonary artery systolic pressure derived from transthoracic echo (ePASP) with pulmonary artery systolic pressure measured during right heart catheterization (cPASP).
METHODS
Single center retrospective study, patients being evaluated for liver transplant (n = 31) who had an interpretable Doppler signal for ePASP and had right heart catheterization (RHC) measurements within 3 months constituted the study group. Control group (n = 49) consisted of patients who did not have liver disease.
RESULTS
There was modest correlation between ePASP and cPASP (R = 0.58, p < 0.001) in LT candidates (n = 31) compared with the control group (R = 0.74, p < 0.001, n = 49). The 95% limits of agreement by Bland-Altman analysis ranged from +33.6 mmHg to −21.7 mmHg. Using receiver operating characteristic analysis, ePASP cut-off > 47 mmHg was 59% sensitive and 78% specific to diagnose pulmonary artery (PA) hypertension (mean PA pressure > 25 mmHg) in the LT candidates, while a similar cutoff performed well in the control group (cutoff > 43 mmHg, n = 47, 91% sensitive, 100% specific).
CONCLUSIONS
Compared with other disease states, ePASP correlates modestly with cPASP in patients with advanced liver disease. A higher ePASP cutoff should be used to screen for pulmonary hypertension. A multi-center prospective study with simultaneous transthoracic echocardiography and RHC measurements is required to determine the best cut-off in this population.

Keyword

Pulmonary hypertension; Cirrhosis; Portopulmonary hypertension; Echocardiography; Liver transplant

MeSH Terms

Blood Pressure
Cardiac Catheterization*
Cardiac Catheters*
Catheterization
Catheters
Echocardiography*
Fibrosis
Heart*
Humans
Hypertension
Hypertension, Pulmonary
Liver Diseases
Liver*
Prospective Studies
Pulmonary Artery*
Retrospective Studies
ROC Curve

Figure

• 

  Figure 1 Study population flow chart.

• 

  Figure 2 (A) cPASP vs. ePASP in liver transplant candidates shows modest correlation (r = 0.58, p = 0.006). (B) cPASP vs. ePASP in control group shows stronger correlation (r = 0.74, p < 0.001). cPASP: pulmonary artery systolic pressure measured during right heart catheterization, ePASP: pulmonary artery systolic pressure derived from transthoracic echocardiography.

• 

  Figure 3 (A) Bland Altman plot analysis of liver transplant candidates reveals bias for ePASP-cPASP of 5.9 mmHg with 95% limits of agreement ranging from +33.6 to -21.7 mmHg. (B) Bland Altman plot analysis of control group, revealing bias for ePASP-cPASP of -0.1 mmHg with 95% limits of agreement ranging from +30.1 and -30.4 mmHg. cPASP: pulmonary artery systolic pressure measured during right heart catheterization, ePASP: pulmonary artery systolic pressure derived from transthoracic echocardiography.

• 

  Figure 4 ROC analysis in liver transplant candidates demonstrate that ePASP cut-off > 47 mmHg was only 59% sensitive and 78% specific; area under curve = 0.7, positive predictive value = 73.3%, negative predictive value = 61%. ePASP: pulmonary artery systolic pressure derived from transthoracic echocardiography, ROC: receiver operating characteristic.

Reference

1. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2015; 46:903–975.

2. Kia L, Shah SJ, Wang E, et al. Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation. Am J Transplant. 2013; 13:2395–2401.

3. Krowka MJ, Mandell MS, Ramsay MA, et al. Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl. 2004; 10:174–182.

4. Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB; ERS Task Force Pulmonary-Hepatic Vascular Disorders (PHD) Scientific Committee. Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J. 2004; 24:861–880.

5. Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006; 48:2546–2552.

6. Steckelberg RC, Tseng AS, Nishimura R, Ommen S, Sorajja P. Derivation of mean pulmonary artery pressure from noninvasive parameters. J Am Soc Echocardiogr. 2013; 26:464–468.

7. Hua R, Sun YW, Wu ZY, et al. Role of 2-dimensional Doppler echo-cardiography in screening portopulmonary hypertension in portal hypertension patients. Hepatobiliary Pancreat Dis Int. 2009; 8:157–161.

8. Cotton CL, Gandhi S, Vaitkus PT, et al. Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl. 2002; 8:1051–1054.

9. Torregrosa M, Genesca J, Gonzalez A, et al. Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates. Transplantation. 2001; 71:572–574.

10. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985; 6:750–756.

11. Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ. Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol. 1987; 9:549–554.

12. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984; 70:657–662.

13. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010; 23:685–713. quiz 786-8.

14. Chemla D, Castelain V, Humbert M, et al. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest. 2004; 126:1313–1317.

15. Krowka MJ, Miller DP, Barst RJ, et al. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest. 2012; 141:906–915.

16. Hervé P, Lebrec D, Brenot F, et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J. 1998; 11:1153–1166.

17. Salgia RJ, Goodrich NP, Simpson H, Merion RM, Sharma P. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era. Dig Dis Sci. 2014; 59:1976–1982.

18. Bozbas SS, Bozbas H. Portopulmonary hypertension in liver transplant candidates. World J Gastroenterol. 2016; 22:2024–2029.

19. Swanson KL, Wiesner RH, Nyberg SL, Rosen CB, Krowka MJ. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant. 2008; 8:2445–2453.

20. Bozbas SS, Eyuboglu FO, Arslan NG, Ergur FO, Karakayali H, Haberal M. The prevalence and the impact of portopulmonary hypertension on postoperative course in patients undergoing liver transplantation. Transplant Proc. 2009; 41:2860–2863.

21. Krowka MJ, Plevak DJ, Findlay JY, Rosen CB, Wiesner RH, Krom RA. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000; 6:443–450.

22. Raevens S, Colle I, Reyntjens K, et al. Echocardiography for the detection of portopulmonary hypertension in liver transplant candidates: an analysis of cutoff values. Liver Transpl. 2013; 19:602–610.

23. Kim WR, Krowka MJ, Plevak DJ, et al. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl. 2000; 6:453–458.

24. Colle IO, Moreau R, Godinho E, et al. Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study. Hepatology. 2003; 37:401–409.

25. Finkelhor RS, Lewis SA, Pillai D. Limitations and strengths of Doppler/echo pulmonary artery systolic pressure-right heart catheterization correlations: a systematic literature review. Echocardiography. 2015; 32:10–18.

26. Farber HW, Foreman AJ, Miller DP, McGoon MD. REVEAL Registry: correlation of right heart catheterization and echocardiography in patients with pulmonary arterial hypertension. Congest Heart Fail. 2011; 17:56–64.

27. Testani JM, St John Sutton MG, Wiegers SE, Khera AV, Shannon RP, Kirkpatrick JN. Accuracy of noninvasively determined pulmonary artery systolic pressure. Am J Cardiol. 2010; 105:1192–1197.